Unlock instant, AI-driven research and patent intelligence for your innovation.

Carbazole formulations for the treatment of psoriasis and angiogenesis

a technology of angiogenesis and cyclosporine, which is applied in the direction of biocide, drug composition, immunodeficiency, etc., can solve the problems of affecting the treatment effect, affecting the development of effective preventive and treatment methods, and affecting the effect of cyclosporine us

Inactive Publication Date: 2006-01-05
ARBISER JACK
View PDF15 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0013] Accordingly, in another aspect, the invention pertains to a method for treating disorders associated with a rac signaling pa

Problems solved by technology

Mild psoriasis is treated with primarily topical glucocorticoids, and other topical agents such as vitamin D and topical retinoids having a smaller role due to decreased efficacy.
While these therapies are effective under some settings, all of them are associated with side effects.
Hepatotoxicity is a major issue for long-term use of methotrexate and retinoids, while hypertension, nephropathy and systemic immunosuppression complicate the use of cyclosporine.
Development of effective preventive and treatment means has been hampered by inadequate understanding of the factors controlling this process.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Carbazole formulations for the treatment of psoriasis and angiogenesis
  • Carbazole formulations for the treatment of psoriasis and angiogenesis
  • Carbazole formulations for the treatment of psoriasis and angiogenesis

Examples

Experimental program
Comparison scheme
Effect test

example 1

Identification of Active Ingredient in Coal Tar

[0059] Liquid extract of coal tar was concentrated under vacuum to get crude extract (20.0 mg). This extract was applied on a Sephadex LH 20 (3.0×100 cm) column and eluted with MeOH. The elution was monitored by TLC and similar fractions are combined to get 11 fractions. This fraction was assayed for inhibition of SVR cell viability (Arbiser et al. (1999) J. Am. Acad. Dermatol. 40, 925-929; and Bai et al. (2003) J. Biol. Chem. 278, 35501-35507). One fraction was found to have activity, and induce a characteristic morphologic change in SVR cells. These changes are similar to what is observed when SVR cells are treated with an EGFR tyrosine kinase inhibitor.

[0060] Fraction 5 (0.5 mg) and fraction 6 (1.2 mg) tested positive in the bioassay. TLC comparison of these two fractions revealed the presence of one common UV-active component in both fractions that produced a blue char upon spraying with H2SO4. Fraction 6 (1.2 mg) was subjected to...

example 2

Identification of Active Carbazole Derivatives by Inhibition of Endothelial Proliferation

[0061] Coal tar fractions were tested for their ability to inhibit the proliferation of SVR cells, an established angiogenic bioassay. One fraction was found to have activity, and induce a characteristic morphologic change in SVR cells.

[0062] Since carbazole is known to be metabolized by mammals through hydroxylation, hydroxylated and oxidized derivatives of carbazole, including 2,3, and 4 hydroxylated carbazoles, were also tested for their anti-proliferative activity using SVR cells as previously described (Arbiser et al. (1999) Supra; and Bai et al. (2003) Supra). As shown in FIG. 1, carbazole itself had mild antiproliferative activity, while 2-, 3- and 4-hydroxy carbazole had more potent antiproliferative activity. These findings suggest that carbazole and its derivatives have antiangiogenic and antisignalling activities.

example 3

Drosophila Assay

[0063] The epidermal growth factor receptor pathway controls cell fate throughout phylogeny. Binding of secreted ligands to EGFR on the cell surface initiates a cascade of events that ultimately invokes transcriptional changes in the nucleus. Ligand / receptor interactions are of critical importance during Drosophila eye development, as recruitment and differentiation of almost all photoreceptors are dependent on high levels of activation of the EGFR pathway. Binding of activating ligand to EGFR results in a cascade of membranous and cytoplasmic phosphorylation events.

[0064] In order to test whether carbazole and its derivatives affect EGFR, the compounds were tested using a novel EGFR assay that is amenable to high throughput screening. Drosophila melanogaster that possess an active EGFR have a distinct eye phenotype, and treatment of mutant Drosophila with carbazole and 4-hydroxycarbazole resulted in correction of the phenotypic defect. Carbazole and 4-hydroxycarba...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Percent by massaaaaaaaaaa
Fractionaaaaaaaaaa
Weightaaaaaaaaaa
Login to View More

Abstract

The methods and compositions disclosed herein relate to using carbazole, and derivatives thereof to modify a signaling activity such as epidermal growth factor receptor (EGFR) signalling, and angiogenesis activity, in a cell.

Description

CROSS-REFERENCE TO RELATED APPLICATION [0001] This application claims the benefit of priority of U.S. Ser. No. 60 / 580,050, filed Jun. 16, 2004, entitled “Carbazole Formulations for the Treatment of Angiogenesis,” the teachings of which are expressly incorporated herein by reference.STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH [0002] The U.S. government has certain rights in this invention by virtue of NIAMS Grants RO3AR44947 to J. L. Arbiser, Emory Skin Disease Research Core Center P30 AR 42687 and RO1 47901 to J. L. Arbiser.FIELD OF THE INVENTION [0003] The invention is generally in the field of methods and compositions for inhibiting angiogenesis and signal transduction. BACKGROUND OF THE INVENTION [0004] Psoriasis is a common inflammatory condition found in 1-2% of the population. Mild psoriasis is treated with primarily topical glucocorticoids, and other topical agents such as vitamin D and topical retinoids having a smaller role due to decreased efficacy. Severe psoriasis i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/695A61K31/675A61K31/55
CPCA61K31/403A61K31/695A61K31/675A61K31/55A61P1/00A61P17/00A61P17/06A61P17/10A61P19/02A61P35/00A61P37/00A61K9/06A61K9/107
Inventor ARBISER, JACK
Owner ARBISER JACK